Found: 126
Select item for more details and to access through your institution.
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0303449
- By:
- Publication type:
- Article
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e690, doi. 10.1093/oncolo/oyad342
- By:
- Publication type:
- Article
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus , Lactobacillus (L.) acidophilus , Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus.
- Published in:
- Microorganisms, 2024, v. 12, n. 4, p. 662, doi. 10.3390/microorganisms12040662
- By:
- Publication type:
- Article
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity.
- Published in:
- Microorganisms, 2024, v. 12, n. 4, p. 718, doi. 10.3390/microorganisms12040718
- By:
- Publication type:
- Article
Peripheral nervous system adverse events associated with immune checkpoint inhibitors.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 6, p. 2975, doi. 10.1007/s00415-023-11625-1
- By:
- Publication type:
- Article
Anti- Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis.
- Published in:
- Microorganisms, 2023, v. 11, n. 6, p. 1551, doi. 10.3390/microorganisms11061551
- By:
- Publication type:
- Article
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 2, p. 572, doi. 10.1007/s00259-022-05944-0
- By:
- Publication type:
- Article
Mechanisms of resistance to last generation EGFR Inhibitors: hijacking NRG1/ERBB3 axis.
- Published in:
- Italian Journal of Anatomy & Embryology / Archivio Italiano di Anatomia Ed Embriologia, 2023, p. 90
- By:
- Publication type:
- Article
Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis.
- Published in:
- 2023
- By:
- Publication type:
- journal article
The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5845, doi. 10.3390/cancers14235845
- By:
- Publication type:
- Article
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4610, doi. 10.3390/cancers14194610
- By:
- Publication type:
- Article
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810292
- By:
- Publication type:
- Article
Thoracic myopericytoma in an older adult, rare but possible: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 17, p. 2532, doi. 10.1111/1759-7714.14535
- By:
- Publication type:
- Article
The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 8, p. e3107, doi. 10.1210/clinem/dgac359
- By:
- Publication type:
- Article
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143472
- By:
- Publication type:
- Article
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence.
- Published in:
- Clinical Oral Investigations, 2022, v. 26, n. 4, p. 3613, doi. 10.1007/s00784-021-04330-8
- By:
- Publication type:
- Article
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02309-1
- By:
- Publication type:
- Article
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 2, p. 247, doi. 10.1007/s40257-021-00645-0
- By:
- Publication type:
- Article
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1461, doi. 10.3390/jcm11051461
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 271, doi. 10.3390/cancers14020271
- By:
- Publication type:
- Article
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 190, doi. 10.1007/s10637-021-01166-7
- By:
- Publication type:
- Article
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization.
- Published in:
- Italian Journal of Anatomy & Embryology / Archivio Italiano di Anatomia Ed Embriologia, 2022, v. 126, p. 117
- By:
- Publication type:
- Article
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e69, doi. 10.1016/j.cllc.2021.10.009
- By:
- Publication type:
- Article
Regolazione del prezzo e rimborso dei farmaci: comparatori, endpoint e ruolo della costo-efficacia.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 99, doi. 10.33393/grhta.2022.2475
- By:
- Publication type:
- Article
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 1, p. 43, doi. 10.1007/s11523-021-00865-8
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 423, doi. 10.1016/j.cllc.2021.03.005
- By:
- Publication type:
- Article
Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 3, p. 675, doi. 10.1002/ijc.33592
- By:
- Publication type:
- Article
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02023-4
- By:
- Publication type:
- Article
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not Enough.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3492, doi. 10.3390/cancers13143492
- By:
- Publication type:
- Article
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00286-w
- By:
- Publication type:
- Article
It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.692491
- By:
- Publication type:
- Article
The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 5, p. 795, doi. 10.3390/diagnostics11050795
- By:
- Publication type:
- Article
Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1758, doi. 10.3390/cancers13081758
- By:
- Publication type:
- Article
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.633543
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 1, p. 219, doi. 10.1007/s10549-020-06001-w
- By:
- Publication type:
- Article
nab -Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.569715
- By:
- Publication type:
- Article
IFN-γ and CD38 in Hyperprogressive Cancer Development.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 309, doi. 10.3390/cancers13020309
- By:
- Publication type:
- Article
Real-world data: come possono aiutare a migliorare la qualità dell'assistenza.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 134, doi. 10.33393/grhta.2021.2286
- By:
- Publication type:
- Article
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211058391
- By:
- Publication type:
- Article
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 19, doi. 10.3390/vaccines9010019
- By:
- Publication type:
- Article
Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1109, doi. 10.3390/diagnostics10121109
- By:
- Publication type:
- Article
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis.
- Published in:
- Journal of Fungi, 2020, v. 6, n. 4, p. 1, doi. 10.3390/jof6040225
- By:
- Publication type:
- Article
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920954802
- By:
- Publication type:
- Article
The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3129, doi. 10.3390/cancers12113129
- By:
- Publication type:
- Article
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920952994
- By:
- Publication type:
- Article
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 4, p. 449, doi. 10.1007/s11523-020-00738-6
- By:
- Publication type:
- Article
New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920913801
- By:
- Publication type:
- Article